Drew Roberts is an associate in the Washington, D.C. office of Latham & Watkins and a member of the firm’s Intellectual Property Litigation Practice.
Drew primarily handles patent litigation. His experience includes representing clients in a variety of venues, including suits in federal district court, inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB), and proceedings outside of the United States.
He advises clients on a variety of matters, particularly for patents related to medical technologies and pharmaceuticals.
In addition to his intellectual property practice, Drew maintains an active pro bono practice, including representing individuals seeking asylum, disabled veterans, and clients seeking to seal old criminal records.
While in law school, Drew served as the lead articles and notes editor of the Texas Environmental Law Journal and a staff editor for the Texas Intellectual Property Law Journal.
Prior to attending law school, Drew performed post-baccalaureate research at the Los Alamos National Laboratory.
Drew graduated from the University of North Carolina at Chapel Hill with a BS in Physics and Political Science, as well as a minor in Mathematics.
Experience
Drew's experience includes representing:
An internationally renowned vision company in a copyright and patent case involving cataract laser surgery products, including proceedings in the District of Delaware, before the PTAB, and in foreign venues, which resulted in a favorable settlement
A leading pharmaceutical company, in the District of Delaware, as the plaintiff of patent infringement claims against a competitor
A leading pharmaceutical company, in the District of Delaware and in foreign venues, as the plaintiff against infringing generic competitors, which resulted in favorable settlements
A major technology company in its IPR challenges against a competitor before the PTAB
A pharmaceutical company, in the District of New Jersey, as the plaintiff in Hatch-Waxman litigation against a generic competitor, which resulted in a favorable settlement
A major medical device company in its intellectual property diligence for the acquisition of another company
Pro bono clients including asylum seekers and veterans
Qualifications
Bar Qualification
California
District of Columbia
Education
JD, University of Texas School of Law, 2020
BS in Physics & Political Science, University of North Carolina, Chapel Hill, 2016
A Latham team led by Mike Morin and David Frazier won the “Litigators of the Week” competition, alongside co-counsel at Finnegan, for their outstanding defense against a US$290 million patent infringement claim and securing a US$116 million award on behalf of Sarepta Therapeutics, in a one-week timed trial in Delaware.
Latham secured a US$115 million verdict for Sarepta Therapeutics and the University of Western Australia in a patent infringement claim against Nippon Shinyaku.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.
